These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36322904)

  • 61. Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.
    Slatter DA; Percy CL; Allen-Redpath K; Gajsiewicz JM; Brooks NJ; Clayton A; Tyrrell VJ; Rosas M; Lauder SN; Watson A; Dul M; Garcia-Diaz Y; Aldrovandi M; Heurich M; Hall J; Morrissey JH; Lacroix-Desmazes S; Delignat S; Jenkins PV; Collins PW; O'Donnell VB
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563336
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.
    Kitazawa T; Igawa T; Sampei Z; Muto A; Kojima T; Soeda T; Yoshihashi K; Okuyama-Nishida Y; Saito H; Tsunoda H; Suzuki T; Adachi H; Miyazaki T; Ishii S; Kamata-Sakurai M; Iida T; Harada A; Esaki K; Funaki M; Moriyama C; Tanaka E; Kikuchi Y; Wakabayashi T; Wada M; Goto M; Toyoda T; Ueyama A; Suzuki S; Haraya K; Tachibana T; Kawabe Y; Shima M; Yoshioka A; Hattori K
    Nat Med; 2012 Oct; 18(10):1570-4. PubMed ID: 23023498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials.
    Shibasaki F; Takeyama M; Ogiwara K; Furukawa S; Nakajima Y; Shimonishi N; Nogami K
    Int J Hematol; 2023 May; 117(5):669-677. PubMed ID: 36607560
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.
    Parker ET; Lollar P
    Biochemistry; 2007 Aug; 46(34):9737-42. PubMed ID: 17676877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies.
    Scheiflinger F; Dockal M; Rosing J; Kerschbaumer RJ
    J Thromb Haemost; 2008 Feb; 6(2):315-22. PubMed ID: 18088341
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity.
    Wakabayashi H; Fay PJ
    Biochemistry; 2013 Jun; 52(22):3921-9. PubMed ID: 23659383
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
    Saenko EL; Shima M; Gilbert GE; Scandella D
    J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional characteristics of N8, a new recombinant FVIII.
    Christiansen ML; Balling KW; Persson E; Hilden I; Bagger-Sørensen A; Sørensen BB; Viuff D; Segel S; Klausen NK; Ezban M; Lethagen S; Steenstrup TD; Kjalke M
    Haemophilia; 2010 Nov; 16(6):878-87. PubMed ID: 20546031
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.
    Csencsits-Smith K; Grushin K; Stoilova-McPhie S
    J Blood Disord Transfus; 2015 Dec; 6(6):325. PubMed ID: 28936365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The association of human coagulation factors VIII, IXa and X with phospholipid vesicles involves both electrostatic and hydrophobic interactions.
    Atkins JS; Ganz PR
    Mol Cell Biochem; 1992 May; 112(1):61-71. PubMed ID: 1513335
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.
    Leong L; Sim D; Patel C; Tran K; Liu P; Ho E; Thompson T; Kretschmer PJ; Wakabayashi H; Fay PJ; Murphy JE
    Blood; 2015 Jan; 125(2):392-8. PubMed ID: 25331117
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epitope specificity and inactivation mechanisms of factor VIII inhibitor antibodies.
    Scandella D
    Vox Sang; 1999; 77 Suppl 1():17-20. PubMed ID: 10529680
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development and characterization of recombinant ovine coagulation factor VIII.
    Zakas PM; Gangadharan B; Almeida-Porada G; Porada CD; Spencer HT; Doering CB
    PLoS One; 2012; 7(11):e49481. PubMed ID: 23152911
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Factor VIII-driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry.
    Freato N; Ebberink EHTM; van Galen J; Fribourg C; Boon-Spijker M; van Alphen FPJ; Meijer AB; van den Biggelaar M; Mertens K
    Blood; 2020 Dec; 136(23):2703-2714. PubMed ID: 32678887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A modified thrombin generation test for the measurement of factor VIII concentrates.
    McIntosh JH; Owens D; Lee CA; Raut S; Barrowcliffe TW
    J Thromb Haemost; 2003 May; 1(5):1005-11. PubMed ID: 12871369
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factor VIII light chain contains a binding site for factor X that contributes to the catalytic efficiency of factor Xase.
    Takeyama M; Wakabayashi H; Fay PJ
    Biochemistry; 2012 Jan; 51(3):820-8. PubMed ID: 22224589
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.
    Yang X; Walsh PN
    Biochem J; 2005 Aug; 390(Pt 1):157-67. PubMed ID: 15755260
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of a next generation factor VIII mimetic bispecific antibody (Mim8) on assays of factor VIII activity and thrombin generation.
    Bowyer AE; Kitchen S; Ezban M
    J Thromb Haemost; 2023 Mar; 21(3):480-487. PubMed ID: 36696203
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.
    Kosloski MP; Shetty KA; Wakabayashi H; Fay PJ; Balu-Iyer SV
    AAPS J; 2014 Sep; 16(5):1038-45. PubMed ID: 24934295
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes.
    Dalm D; Galaz-Montoya JG; Miller JL; Grushin K; Villalobos A; Koyfman AY; Schmid MF; Stoilova-McPhie S
    Sci Rep; 2015 Jun; 5():11212. PubMed ID: 26082135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.